Edmond de Rothschild Holding’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Buy |
54,826
+12,840
| +31% | +$6.16M | 0.36% | 74 |
|
|
2026
Q1 | $20.6M | Sell |
41,986
-1,979
| -5% | -$1.07M | 0.3% | 87 |
|
|
2025
Q4 | $25.5M | Sell |
43,965
-5,840
| -12% | -$3.3M | 0.36% | 76 |
|
|
2025
Q3 | $24.2M | Buy |
49,805
+4,161
| +9% | +$1.94M | 0.37% | 69 |
|
|
2025
Q2 | $18.5M | Buy |
45,644
+6,141
| +16% | +$2.57M | 0.3% | 85 |
|
|
2025
Q1 | $19.7M | Buy |
39,503
+3,236
| +9% | +$1.75M | 0.35% | 79 |
|
|
2024
Q4 | $18.9M | Buy |
36,267
+348
| +1% | +$191K | 0.32% | 81 |
|
|
2024
Q3 | $22.2M | Sell |
35,919
-12,543
| -26% | -$7.42M | 0.36% | 78 |
|
|
2024
Q2 | $26.8M | Sell |
48,462
-5,526
| -10% | -$3.17M | 0.46% | 59 |
|
|
2024
Q1 | $31.4M | Sell |
53,988
-1,259
| -2% | -$706K | 0.52% | 50 |
|
|
2023
Q4 | $29.3M | Sell |
55,247
-1,457
| -3% | -$705K | 0.52% | 52 |
|
|
2023
Q3 | $28.7M | Buy |
56,704
+3,653
| +7% | +$1.95M | 0.58% | 47 |
|
|
2023
Q2 | $27.7M | Sell |
53,051
-528
| -1% | -$285K | 0.55% | 47 |
|
|
2023
Q1 | $30.9M | Sell |
53,579
-2,674
| -5% | -$1.51M | 0.7% | 38 |
|
|
2022
Q4 | $31M | Sell |
56,253
-5,060
| -8% | -$2.68M | 0.72% | 40 |
|
|
2022
Q3 | $31.1M | Buy |
61,313
+2,048
| +3% | +$1.15M | 0.82% | 30 |
|
|
2022
Q2 | $32.2M | Sell |
59,265
-3,386
| -5% | -$1.86M | 0.78% | 30 |
|
|
2022
Q1 | $37M | Sell |
62,651
-6,868
| -10% | -$3.95M | 0.8% | 37 |
|
|
2021
Q4 | $46.4M | Sell |
69,519
-7,438
| -10% | -$4.64M | 1% | 23 |
|
|
2021
Q3 | $44M | Buy |
76,957
+2,751
| +4% | +$1.51M | 1.02% | 21 |
|
|
2021
Q2 | $37.4M | Buy |
74,206
+23,430
| +46% | +$11.1M | 0.86% | 27 |
|
|
2021
Q1 | $23.2M | Sell |
50,776
-506
| -1% | -$242K | 0.64% | 43 |
|
|
2020
Q4 | $23.9M | Buy |
51,282
+4,045
| +9% | +$1.9M | 0.8% | 28 |
|
|
2020
Q3 | $20.9M | Sell |
47,237
-3,009
| -6% | -$1.24M | 0.83% | 35 |
|
|
2020
Q2 | $18.2M | Buy |
50,246
+6,203
| +14% | +$2.08M | 0.75% | 40 |
|
|
2020
Q1 | $12.5M | Sell |
44,043
-6,978
| -14% | -$2.2M | 0.65% | 39 |
|
|
2019
Q4 | $16.6M | Sell |
51,021
-300
| -0.6% | -$91K | 0.65% | 49 |
|
|
2019
Q3 | $14.9M | Sell |
51,321
-3,916
| -7% | -$1.12M | 0.6% | 49 |
|
|
2019
Q2 | $16.2M | Buy |
55,237
+1,407
| +3% | +$388K | 0.61% | 44 |
|
|
2019
Q1 | $14.7M | Sell |
53,830
-2,600
| -5% | -$647K | 0.51% | 55 |
|
|
2018
Q4 | $12.6M | Sell |
56,430
-14,460
| -20% | -$3.39M | 0.44% | 63 |
|
|
2018
Q3 | $17.3M | Hold |
70,890
| – | – | 0.49% | 57 |
|
|
2018
Q2 | $14.7M | Sell |
70,890
-3,840
| -5% | -$815K | 0.42% | 60 |
|
|
2018
Q1 | $15.4M | Sell |
74,730
-9,300
| -11% | -$1.95M | 0.45% | 63 |
|
|
2017
Q4 | $16M | Sell |
84,030
-42,070
| -33% | -$8.06M | 0.46% | 64 |
|
|
2017
Q3 | $23.9M | Sell |
126,100
-7,185
| -5% | -$1.3M | 0.68% | 44 |
|
|
2017
Q2 | $23.3M | Hold |
133,285
| – | – | 0.66% | 44 |
|
|
2017
Q1 | $20.5M | Buy |
133,285
+2,830
| +2% | +$433K | 0.54% | 58 |
|
|
2016
Q4 | $18.4M | Buy |
130,455
+38,880
| +42% | +$5.73M | 0.51% | 60 |
|
|
2016
Q3 | $14.6M | Hold |
91,575
| – | – | 0.44% | 66 |
|
|
2016
Q2 | $13.5M | Sell |
91,575
-7,540
| -8% | -$1.11M | 0.43% | 65 |
|
|
2016
Q1 | $14M | Sell |
99,115
-34,040
| -26% | -$4.56M | 0.45% | 66 |
|
|
2015
Q4 | $18.9M | Sell |
133,155
-400
| -0.3% | -$53.4K | 0.5% | 57 |
|
|
2015
Q3 | $16.3M | Buy |
133,555
+15,955
| +14% | +$2.08M | 0.4% | 65 |
|
|
2015
Q2 | $15.3M | Buy |
+117,600
| New | +$15.3M | 0.33% | 72 |
|
Other funds holding TMO
Edmond de Rothschild Holding's TMO Position: Q2 2026 in Review
Edmond de Rothschild Holding increased its Thermo Fisher Scientific (TMO) stake by 31% in Q2 2026, buying an estimated $6.16M and bringing the position to 54,826 shares worth $27.5M. The position accounts for 0.36% of the portfolio, ranked #74.
Edmond de Rothschild Holding first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $46.4M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Edmond de Rothschild Holding held 54,826 shares of Thermo Fisher Scientific worth $27.5M as of Q2 2026.
- Edmond de Rothschild Holding bought 12,840 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.16M.
- Thermo Fisher Scientific made up 0.36% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #74 holding.
- Edmond de Rothschild Holding first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
- Edmond de Rothschild Holding's Thermo Fisher Scientific position peaked at $46.4M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.